Allen & Overy and Frotz Riedl advise private equity investor CMR on acquisition of laser specialist Rofin Sinar UK
16 October 2017
RSUK is specialised in the manufacturing of low power carbon dioxide (CO2) lasers.
The acquisition of RSUK by CMR was the consequence of a condition stipulated by the European Commission in connection with the acquisition of Rofin-Sinar Technologies Inc. (RSUK’s former parent company) by Coherent in 2016. In order to avoid a dominant market position, RSUK had to be sold.
In connection with the acquisition of RSUK by CMR, Rofin-Sinar UK and Iradion Laser Inc. also agreed on a joint worldwide sales, service and production cooperation. Both companies are specialists in the development and manufacturing of CO2 laser sources. The now combined product portfolios cover a wide range of CO2 lasers with low power levels up to 1kW.
CMR was advised by a team led by Allen & Overy partner Dr. Helge Schäfer and counsel Dr. Jonas Wittgens (both Corporate, Hamburg). The Allen & Overy team further comprised partners Cathy Bell-Walker (Banking & Finance, London) and Dr. Ellen Braun (Antitrust, Hamburg), London partners Stephen Mathews (Corporate) and Paul McCarthy (Employment & Benefits) as well as senior associate Fatih Coskun (Banking & Finance, Frankfurt) and associates Jonathan Down (Corporate, London), Dr. Moritz Merkenich (Corporate, Hamburg) and Yves Holle (Antitrust, Hamburg).
On matters of Austrian law, in particular on acquisition structure and financing, CMR was advised by partners Dr. Stephan Frotz and Dr. Paul Schörghofer (both Corporate) as well as Dr. Clemens Spitznagel (Finance) of Frotz Riedl Rechtsanwälte (Vienna). The team of Frotz Riedl Rechtsanwälte further comprised associates Mag. Andrei Demian (Corporate) and Felicitas Abel (Finance).
On matters of tax law, CMR was advised by Ernst & Young (Vienna).